Mon, January 3, 2011
Fri, December 31, 2010
Thu, December 30, 2010
Wed, December 29, 2010
Tue, December 28, 2010
Mon, December 27, 2010
Fri, December 24, 2010
Thu, December 23, 2010
Wed, December 22, 2010
Tue, December 21, 2010
Mon, December 20, 2010
Fri, December 17, 2010
Thu, December 16, 2010
Wed, December 15, 2010
Tue, December 14, 2010
Mon, December 13, 2010
Sun, December 12, 2010
Fri, December 10, 2010
Thu, December 9, 2010
Wed, December 8, 2010
Tue, December 7, 2010
Mon, December 6, 2010
Fri, December 3, 2010
Thu, December 2, 2010

AngioDynamics to Report Fiscal 2011 Second Quarter Financial Results and Hold Conference Call on January 4, 2011


//health-fitness.news-articles.net/content/2010/ .. -and-hold-conference-call-on-january-4-2011.html
Published in Health and Fitness on by Market Wire   Print publication without navigation


ALBANY, N.Y.--([ BUSINESS WIRE ])--AngioDynamics (NASDAQ: ANGO), a leading provider of innovative medical devices for the minimally-invasive treatment of cancer and peripheral vascular disease, today announced that it will report its fiscal 2011 second quarter financial results on Tuesday, January 4, 2011, after the close of the U.S. financial markets.

Jan Keltjens, President and Chief Executive Officer, and Joseph Gersuk, Executive Vice President and Chief Financial Officer, will host an investment community conference call beginning at 4:30 p.m. Eastern Time on January 4, 2011, to discuss the quartera�s results and to answer questions.

To participate in the live call by telephone, please dial +1 (877) 941-6009.

Those interested in listening to the conference call live via the Internet may do so by visiting the Investor Relations section of AngioDynamicsa� Web site at [ http://investors.angiodynamics.com ]. To listen to the live call, please go to the Web site 15 minutes prior to its start to register, download and install the necessary audio software. The conference call will also be archived on the Web site.

About AngioDynamics

AngioDynamics, Inc. is a leading provider of innovative medical devices used by interventional radiologists, surgeons and other physicians for the minimally-invasive treatment of cancer and peripheral vascular disease. AngioDynamics' diverse product lines include market-leading radiofrequency and irreversible electroporation ablation systems, vascular access products, angiographic products and accessories, dialysis products, angioplasty products, drainage products, thrombolytic products, embolization products and venous products. More information is available at [ www.angiodynamics.com ].


Publication Contributing Sources